Wyeth and Progenics Receive Approval from European Commission for RELISTOR fo bi13651419 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection from the European Commission. RELISTOR now approved the 27 member states of the European Union as well as Iceland, Norway, and Liechtenstein for the ..

Wyeth and Progenics Receive Approval from European Commission for RELISTOR fo bi13651419 COLLEGEVILLE, Pa., & TARRYTOWN, N.Y.----Wyeth Pharmaceuticals, a division of Wyeth , and Progenics Pharmaceuticals, Inc. , today announced that the companies have received marketing approval for RELISTOR? subcutaneous injection from the European Commission

NIH Grant Of $5.6 Million Awarded To USU Researchers To Fight Deadly Viruses bi13651419 Researchers at the Uniformed Services University of the Health Sciences (USU) have been awarded a $5.6 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop and test vaccines and treatments for the deadly Nipah and Hendra viruses. Christopher C. Broder, Ph.D

Using a protein to attack the Achilles? heel of cancers (The Hindu) bi13651419 The NY-ESO1 generates immune response the human body..

Blocking A Single Protein Proves Toxic To Myeloma Cells In Laboratory Studies bi13651419 Researchers have found that cells from a blood-borne cancer called multiple myeloma rely on the activity of a single , IRF4, for the activation of a wide range of genes responsible for cell survival and spread. Blocking the production of can be strikingly effective eliminating cancer cells laboratory models of multiple myeloma

Blocking a Single Protein Proves Toxic to Myeloma Cells Laboratory Studies bi13651419 Researchers have found that cells from a blood-borne cancer called multiple myeloma rely on the activity of a single , IRF4, for the activation of a wide range of genes responsible for cell survival and spread

Blocking a Single Protein Proves Toxic to Myeloma Cells Laboratory Studies bi13651419 Researchers have found that cells from a blood-borne cancer called multiple myeloma rely on the activity of a single , called IRF4, for the activation of a wide range of genes responsible for cell survival and spread

New targeted treatment promising breast cancer (Reuters via Yahoo! News) bi13651419 An novel investigational chemotherapy regimen targeting both a mutated called p53 and tumor blood vessels "has complementary and potent antitumor activity and could define a new strategy for suppression of advanced breast cancers," Dr. Yayun Liang reported at the Department of Defense's annual Era of Hope breast cancer meeting that just wrapped Baltimore, Maryland

Thermo Fisher Scientific Acquires Open Biosystems, Creating Unmatched RNAi Pl bi13651419 Thermo Fisher Scientific Inc., the world leader serving science, announced that has acquired Open Biosystems, Inc., a provider of RNA interference (RNAi), gene expression and detection products for life science research and drug discovery and development..

Soon, a non-invasive tool to monitor lung cancer treatment progress (New Kerala) bi13651419 London, July 4 : Researchers from Massachusetts General Hospital Cancer Centre Boston are developing a blood test that would help monitoring lung cancer progression by detecting tumour cells circulating the bloodstream

Circulating Tumor Cells Reveal Insights Into Lung Cancers (MedicineNet.com) bi13651419 Title: Circulating Tumor Cells Reveal Insights Into Lung Cancers Category: Health News Created: 7/3/2008 2:00:00 AM Last Editorial Review: 7/3/2008..

Amgen Diminished Shares Set for Rebound on Bone Drug (Update1) (Bloomberg.com) bi13651419 July 3 (Bloomberg) -- Amgen Inc. 's experimental osteoporosis drug may become the top remedy for the bone- thinning disorder, gaining about half of an $8 billion annual market and reviving shares

Circulating Tumor Cells Reveal Insights Into Lung Cancers (HealthDay via Yaho bi13651419 WEDNESDAY, July 2 (HealthDay News) -- A new technique for finding and analyzing stray cancer cells the blood of lung cancer patients may make possible for doctors to one day not only determine the genetic "signature" of particular tumors but to monitor changes those cells and adjust treatments accordingly

Antique Garden Furniture - Home